Genelux (GNLX) Interest & Investment Income (2023 - 2026)
Genelux (GNLX) recorded quarterly Interest & Investment Income of $173000.0 in Q1 2026, up 35.16% quarter-over-quarter from $128000.0 in Q4 2025, and down 5.98% on a YoY basis from $184000.0 in Q1 2025.
Genelux (GNLX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Genelux's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $173000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 5.98% year-over-year to $173000.0; the TTM figure through Mar 2026 stood at $700000.0 (down 9.09% YoY), while the FY2025 annual figure was $711000.0, up 1.57% from the prior year.
- Interest & Investment Income was $173000.0 for Q1 2026 at Genelux, up from $128000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $265000.0 in Q1 2024 to a low of $4000.0 in Q3 2023.
- Historically, Interest & Investment Income has averaged $179909.1 across 4 years, with a median of $184000.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income jumped 5450.0% in 2024, then tumbled 36.32% in 2025.
- A 4-year view of Interest & Investment Income shows it stood at $240000.0 in 2023, then fell by 16.25% to $201000.0 in 2024, then sank by 36.32% to $128000.0 in 2025, then soared by 35.16% to $173000.0 in 2026.
- The last three Interest & Investment Income figures came in at $173000.0 (Q1 2026), $128000.0 (Q4 2025), and $175000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 173,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 173,000.00 |
| Dec 31, 2025 | 128,000.00 |
| Sep 30, 2025 | 175,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Mar 31, 2025 | 184,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 222,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Dec 31, 2023 | 240,000.00 |
| Sep 30, 2023 | 4,000.00 |